Foster 200/6 mikrograma po potisku, stlačeni inhalat, otopina
| Name | Foster 200/6 mikrograma po potisku, stlačeni inhalat, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-081899150 |
| Active Substance | beklometazondipropionat formoterolfumarat dihidrat |
| Composition | jedna odmjerena doza (potiskom preko ventila) sadrži: 200 mikrograma beklometazondipropionata i 6 mikrograma formoterolfumarat dihidrata što odgovara isporučenoj dozi (preko nastavka za usta) od 177,7 mikrograma beklometazondipropionata i 5,1 mikrograma formoterolfumarat dihidrata |
| Pharmaceutical Form | stlačeni inhalat, otopina |
| Manufacturer | Chiesi Pharmaceuticals GmbH, Beč, Austrija Chiesi Farmaceutici S.p.A., Parma, Italija Chiesi SAS, La Chaussee Saint Victor , Francuska |
| Marketing Authorisation Holder | Chiesi Pharmaceuticals GmbH, Gonzagagasse 16/16, Beč, Austrija |
| Marketing Authorisation Date | 30.06.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/164 |
| Registration Number | 381-12-01/154-23-08 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | R03AK08 |
| Medicinal product marketed in the Croatia | Ne |
| SmPC | download |
| PL | download |
